- School of Chemistry - Research Publications
School of Chemistry - Research Publications
Permanent URI for this collection
112 results
Filters
Reset filtersSettings
Statistics
Citations
Search Results
Now showing
1 - 10 of 112
-
ItemNo Preview AvailableA cis-β-iron(iii) SALPN catalyst for hydrogen atom transfer reductions and olefin cross couplingsRicca, M ; Yao, S ; Le, T ; White, JM ; Donnelly, PS ; Rizzacasa, MA (ROYAL SOC CHEMISTRY, 2023-08-23)An inexpensive Fe(III) SALPN catalyst for MHAT reactions such as reductions of α,β-unsaturated carbonyl compounds and olefin cross couplings is reported. The majority of these reactions proceeded in good yields and high stereoselectivities with low catalyst loadings at room temperature.
-
ItemNo Preview AvailableSynthesis of More Highly Oxidized Alkyl Citrates via Direct Regio- and Stereoselective Oxidation.Rossouw, NP ; Chen, Z ; White, JM ; Rizzacasa, MA (American Chemical Society (ACS), 2023-11-10)An approach to more highly oxidized alkyl citrates by direct regio- and stereoselective oxidations is reported. The total synthesis and structural assignment of alkyl citrate L-731-128 are described, and the synthesis of its C4 oxidized congener L-731,127 utilized a regio- and stereoselective enolate oxidation with oxygen gas. A highly stereoselective Rubottom oxidation of a cyclic silylketene acetal then enabled oxidation at C2 to afford the cinatrins C1 and C3.
-
ItemNo Preview AvailableHammett Structural Relationships Revealed in Chalcogen-Bonded Co-Crystals of Electron-Rich Pyridines with 4′-Substituted Ebselen DerivativesFellowes, T ; Lee, E ; Tran, J ; Xu, R ; Barber, A ; Brydon, SC ; Clegg, JK ; White, JM (American Chemical Society (ACS), 2023-10-04)
-
ItemNo Preview AvailableMono and binuclear cadmium complexes: X-ray crystal structures, Hirshfeld surface analysis and antimicrobial/antioxidant studiesAkbari, Z ; Montazerozohori, M ; Joohari, S ; Hayati, P ; Micale, N ; Cristani, M ; Bruno, G ; White, JM (Elsevier BV, 2023-12-01)
-
ItemPhotophysics and spectroscopy of 1,2-BenzazuleneAwuku, S ; Bradley, SJ ; Ghiggino, KP ; Steer, RP ; Stevens, AL ; White, JM ; Yeow, C (Elsevier, 2021-12)The electronic spectroscopy and photophysics of 1,2-benzazulene (BzAz) have been examined in solution and in thin solid films, with the objective of comparing its intramolecular and intermolecular excited state decay processes with those of azulene. Unlike azulene, the S2 – S0 absorption and fluorescence spectra exhibit a clear mirror image relationship dominated by a single strong Franck-Condon active progression. Picosecond transient absorption spectra and non-linear S2 fluorescence upconversion experiments reveal lifetimes that follow a well-established energy gap law correlation, indicative of a dominant S2 – S1 decay route. Mechanistic interpretations, including the possibility of S2 singlet fission in aggregates, are discussed.
-
ItemPyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analysesZaib, S ; Younas, MT ; Khan, I ; Ali, HS ; McAdam, CJ ; White, JM ; Jaber, F ; Awwad, NS ; Ibrahium, HA (Elsevier, 2023-12-01)The identification of effective and druggable cholinesterase inhibitors to treat progressive neurodegenerative Alzheimer’s disorder remains a continuous drug discovery hunt. In this perspective, the present study investigates the design and discovery of pyrimidine-morpholine hybrids (5a-l) as potent cholinesterase inhibitors. Palladium-catalyzed Suzuki-Miyaura cross-coupling reaction was employed to introduce the structural diversity on the pyrimidine heterocyclic core. A range of commercially available boronic acids was successfully coupled showing a high functional group tolerance. In vitro cholinesterase inhibitory potential using Ellman’s method revealed significantly strong potency. Compound 5h bearing a meta-tolyl substituent at 2-position of pyrimidine ring emerged as a lead candidate against AChE with an inhibitory potency of 0.43 ± 0.42 µM, ∼38-fold stronger value than neostigmine (IC50 = 16.3 ± 1.12 µM). Compound 5h also showed the lead inhibition against BuChE with an IC50 value of 2.5 ± 0.04 µM. The kinetics analysis of 5h revealed the non-competitive mode of inhibition against AChE whereas computational modelling results of potent leads depicted diverse contacts with the binding site amino acid residues. Molecular dynamics simulations revealed the stability of biomolecular system, while, ADME analysis demonstrated druglikeness behaviour of potent compounds. Overall, the investigated pyrimidine-morpholine scaffold presented a remarkable potential to be developed as efficacious anti-Alzheimer’s drugs.
-
ItemNo Preview AvailableAn approach to assessing the contribution of the high LET effect in strategies for Auger endoradiotherapyLobachevsky, P ; Skene, C ; Munforte, L ; Smith, A ; White, J ; Martin, RF (TAYLOR & FRANCIS LTD, 2023-01-02)Purpose: The interest in exploiting Auger emitters in cancer therapy stems from their high linear energy transfer (LET)-type radiation damage to DNA. However, the design of Auger-emitter labeled vehicles that target the Auger cascade specifically to the DNA of tumour cells is challenging. Here we suggest a possible approach to evaluate tumour-targeting Auger-labeled conjugates by assessing the impact of a radioprotector known to be effective in protecting from low LET radiation, but not high LET radiation. Given some similarity between the energy spectrum of Auger electrons and that of secondary electrons from soft X-rays, we report the results of radioprotection experiments with 25 kVp X-rays. Materials and methods: Clonogenic survival curves for cultured human keratinocytes were established for three different irradiation conditions: 137Cs γ-rays, 25 kVp X-rays and 320 kVp X-rays, and the effect of including a new radioprotector, denoted "2PH", was investigated.Results: The extent of radioprotection by 2PH was comparable for all radiation conditions, although RBE was higher (about 1.7) for soft X-rays. Conclusions: Radioprotectors like 2PH will help to evaluate Auger endoradiotherapy strategies, by determining the relative contributions of the high-LET effects (not protected), compared to other components, such as Auger electrons not effectively targeted to DNA.
-
ItemNo Preview AvailableSynthesis of acyloin natural products by Mukaiyama hydrationRicca, M ; Zhang, W ; Li, J ; Fellowes, T ; White, JM ; Donnelly, PS ; Rizzacasa, MA (ROYAL SOC CHEMISTRY, 2022-04-27)The acyloin natural products are a family of bioactive compounds isolated from fungi and myxobacteria. The total synthesis of 7 members of the acyloin family was achieved via a HWE reaction followed by Mukaiyama-Isayama hydration, using novel Co(II) and Co(III) Schiff base SALPN complexes as catalysts for the key enone hydration step. Furthermore, we have shown that a mild acyloin rearrangement is possible under Mukaiyama hydration conditions, which was crucial in the success of this approach.
-
ItemPre-targeting amyloid-beta with antibodies for potential molecular imaging of Alzheimer's diseaseMorgan, KA ; de Veer, M ; Miles, LA ; Kelderman, CAA ; McLean, CA ; Masters, CL ; Barnham, KJ ; White, JM ; Paterson, BM ; Donnelly, PS (ROYAL SOC CHEMISTRY, 2023-01-17)With the aim of developing the concept of pretargeted click chemistry for the diagnosis of Alzheimer's disease two antibodies specific for amyloid-β were modified to incorporate trans-cyclooctene functional groups. Two bis(thiosemicarbazone) compounds with pendant 1,2,4,5-tetrazine functional groups were prepared and radiolabelled with positron emitting copper-64. The new copper-64 complexes rapidly react with the trans-cyclooctene functionalized antibodies in a bioorthogonal click reaction and cross the blood-brain barrier in mice.
-
ItemBromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomographyDickmann, CGF ; McDonald, AFF ; Huynh, N ; Rigopoulos, A ; Liu, Z ; Guo, N ; Osellame, LDD ; Gorman, MAA ; Parker, MWW ; Gan, HKK ; Scott, AMM ; Ackermann, U ; Burvenich, IJG ; White, JMM (ROYAL SOC CHEMISTRY, 2023-02-14)Bromodomain and extraterminal (BET) proteins, a family of epigenetic regulators, have emerged as important oncology drug targets. BET proteins have not been targeted for molecular imaging of cancer. Here, we report the development of a novel molecule radiolabelled with positron emitting fluorine-18, [18F]BiPET-2, and its in vitro and preclinical evaluation in glioblastoma models.